Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
Axogen, Inc. (AXGN)
Sector: Healthcare; Industry: Medical Devices

AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. AxoGen, Inc. is headquartered in Alachua, Florida.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2019-06-13 Wendell Amy McBride Director Buy 5,000 $20.25 $101,250 No
2019-05-13 Hansen David K VP Finance & Treasurer Sell 20,000 $22.63 $452,600 No
2018-11-30 Freitag Gregory Gene General Counsel Sell 45,000 $33.00 $1,485,000 No
2018-11-15 Freitag Gregory Gene General Counsel Sell 20,000 $32.25 $645,000 No
2018-11-14 Zaderej Karen L. CEO Sell 25,000 $33.18 $829,620 No
2018-08-14 Wendell Amy McBride Director Buy 5,000 $36.89 $184,450 No
2018-05-16 MCCARREY SHAWN F SVP Sales Sell 10,000 $43.47 $434,700 No
2018-02-21 Grooms Jamie Mark Director Sell 57,406 $28.40 $1,630,330 No
2018-02-20 Grooms Jamie Mark Director Sell 63,395 $27.67 $1,754,060 No
2018-02-15 Grooms Jamie Mark Director Sell 95,712 $26.84 $2,568,969 No
2018-02-15 Grooms Jamie Mark VP, CFO Sell 95,712 $26.84 $2,568,969 No
2017-12-12 Grooms Jamie Mark Director Sell 38,405 $26.35 $1,011,806 No
2017-12-08 Grooms Jamie Mark Director Sell 86,595 $26.37 $2,283,667 No
2017-12-08 Grooms Jamie Mark Director Sell 84,295 $26.38 $2,223,722 No
2017-11-20 Essex Woodlands Fund IX, L.P. 10%-Owner Sell 1,150,000 $19.74 $22,701,000 No
2017-11-20 NEELS GUIDO J Director Sell 1,150,000 $19.74 $22,701,000 No
2017-09-11 Rudelius Robert James Director Sell 16,143 $18.00 $290,574 Yes
2016-10-07 Wendell Amy McBride Director Buy 13,333 $7.50 $99,998 No
2016-10-07 Leach Kevin Vice President Marketing Buy 2,000 $7.50 $15,000 No
2016-10-07 MARIANI PETER J Chief Financial Officer Buy 3,333 $7.50 $24,998 No
2016-10-07 Zaderej Karen L. CEO Buy 10,000 $7.50 $75,000 No
2016-10-07 Engels John P VP Buy 4,000 $7.50 $30,000 No
2016-08-09 Mandato Joseph M Director Sell 149,618 $8.54 $1,277,288 No
2016-07-21 Flynn James E Possible Member of 10% Group Sell 102,136 $6.70 $684,311 No
2016-07-18 Flynn James E Possible Member of 10% Group Sell 279,303 $7.53 $2,104,171 No
2015-11-06 Gold Mark Stephen Director Sell 6,013 $5.70 $34,274 No
2015-09-18 Flynn James E Possible Member of 10% Group Sell 345,000 $5.50 $1,897,983 No
2015-06-03 Mandato Joseph M Director Buy 6,500 $3.10 $20,150 No
2015-06-02 Johnston Lee Robert Jr Chief Finacial Officer Buy 5,000 $3.06 $15,303 No
2015-05-27 Zaderej Karen L. Chief Executive Officer Buy 3,325 $3.16 $10,493 No

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.